High-Dose Intravenous Iron with Either Ferric Carboxymaltose or Ferric Derisomaltose: A Benefit-Risk Assessment

The intravenous iron formulations ferric carboxymaltose (FCM) and ferric derisomaltose (FDI) offer the possibility of administering a large amount of iron in one infusion. This results in faster correction of anemia and the formulations being better tolerated than oral iron formulations. This triad...

Descripción completa

Detalles Bibliográficos
Autores principales: Boots, Johannes M. M., Quax, Rogier A. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Benefit-Risk Assessment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492608/
https://www.ncbi.nlm.nih.gov/pubmed/36068430
http://dx.doi.org/10.1007/s40264-022-01216-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492608/
https://www.ncbi.nlm.nih.gov/pubmed/36068430
http://dx.doi.org/10.1007/s40264-022-01216-w

Ejemplares similares